Research ArticleMuscular Dystrophy

Recombinant MG53 Protein Modulates Therapeutic Cell Membrane Repair in Treatment of Muscular Dystrophy

See allHide authors and affiliations

Science Translational Medicine  20 Jun 2012:
Vol. 4, Issue 139, pp. 139ra85
DOI: 10.1126/scitranslmed.3003921

Article Information

vol. 4 no. 139 139ra85

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication February 22, 2012
  • Accepted for publication May 11, 2012

Author Information

  1. Noah Weisleder1,2,*,
  2. Norio Takizawa2,
  3. Peihui Lin1,
  4. Xianhua Wang3,
  5. Chunmei Cao3,
  6. Yan Zhang3,
  7. Tao Tan2,
  8. Christopher Ferrante2,
  9. Hua Zhu1,
  10. Pin-Jung Chen2,
  11. Rosalie Yan2,
  12. Matthew Sterling1,
  13. Xiaoli Zhao1,
  14. Moonsun Hwang1,
  15. Miyuki Takeshima4,
  16. Chuanxi Cai1,
  17. Heping Cheng3,
  18. Hiroshi Takeshima4,
  19. Rui-Ping Xiao3 and
  20. Jianjie Ma1,2,*
  1. 1Department of Physiology and Biophysics, Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA.
  2. 2Protein Therapy Division, TRIM-edicine Inc., North Brunswick, NJ 08902, USA.
  3. 3Institute of Molecular Medicine, Peking University, Beijing 100871, China.
  4. 4Department of Biological Chemistry, Kyoto University Graduate School of Pharmaceutical Sciences, Kyoto 606-8501, Japan.
  1. *To whom correspondence should be addressed. E-mail: noah.weisleder{at}umdnj.edu (N.W.); maj2{at}umdnj.edu (J.M.)

Altmetric

Article usage

Article usage:

No statistics are available.